The RIV-COXIB Capsule is a next-generation NSAID featuring Polmacoxib 2 mg, specifically engineered for effective management of Osteoarthritis and inflammatory joint pain. The RIV-COXIB Capsule is clinically recognized for its quicker onset of action, providing faster relief from pain and stiffness compared to conventional treatments. With its advanced profile, the RIV-COXIB Capsule delivers powerful anti-inflammatory effects while demonstrating a superior gastrointestinal safety margin, making it a trusted choice for both acute and chronic pain conditions.
Key Benefits
✅ Provides rapid and effective relief from Osteoarthritis symptoms
✅ Superior GI safety profile compared to traditional NSAIDs
✅ Potentially minimizes cardiovascular side effects
✅ Lowest daily dose among available NSAIDs for better compliance
✅ Effective for a wide range of conditions from arthritis to sports injuries
Key Ingredient
Polmacoxib (2 mg) – A modern, selective COX-2 inhibitor that targets the source of pain and inflammation with high efficacy. It is distinguished by its fast onset of action, favorable safety profile, and being the lowest-dosed NSAID available.
Why Choose RIV-COXIB Capsule?
The RIV-COXIB Capsule represents a significant advancement in pain management, combining potent efficacy with an enhanced safety profile. Its ability to provide quicker relief than celecoxib, coupled with better GI tolerance, makes it an ideal choice for physicians treating patients with chronic inflammatory conditions like osteoarthritis. The RIV-COXIB Capsule is designed for those who seek powerful pain control without compromising on safety, ensuring improved quality of life and patient satisfaction. It is the smart, modern solution for managing joint pain, post-surgical discomfort, and sports-related injuries.
Reviews
There are no reviews yet.